Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)
Completed · Phase 3 · Has a placebo group
Conditions studied: Fatty Liver
In brief
The purpose of this study is to determine if therapeutic modification of insulin resistance or oxidative stress leads to improvement in serum or histologic indicators of liver injury or quality of life.
Key facts
- Study ID
- NCT00063635
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- People needed
- 173
- Starts
- 2005-09-01
- Expected to finish
- 2010-02-01
- Last updated by the study team
- 2012-09-27
Who can join
Age: 8 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California, San Diego — San Diego, California, United States
- University of California, San Francisco — San Francisco, California, United States
- Children's National Medical Center — Washington D.C., District of Columbia, United States
- Indiana University — Indianapolis, Indiana, United States
- Johns Hopkins University — Baltimore, Maryland, United States
- St. Louis University — St Louis, Missouri, United States
- Case Western Reserve University — Cleveland, Ohio, United States
- Texas Children's Hospital — Houston, Texas, United States
- Virginia Commonwealth University — Richmond, Virginia, United States
- University of Washington — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.